The PDUFA date for Xarelto in AF is on or around 11/5/11, ten months from the submission date (#msg-58447066). The FDA presumably nixed a priority review because Pradaxa is already approved in this indication.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.